百济神州追加投3亿美元
2026-07-24 03:23:06
据界面新闻报道，百济神州宣布追加投资3亿美元，扩建位于美国新泽西州霍普韦尔普林斯顿西部创新园区的旗舰生产基地和临床研发中心，新增小分子药物生产能力，完善全球化生产和供应体系。另据百利天恒公告，其EGFR×HER3双抗ADC伦康依隆妥单抗/宜泽康用于HR+HER2-乳腺癌的III期随机对照临床试验PANKU-Breast03已于近日完成首例受试者入组。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Cramer称多数抛售可逢低买入Next article：
Ripple推出Ripple Mint平台
